| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00268-011-1305-2 |
| P698 | PubMed publication ID | 21976010 |
| P50 | author | Eleftherios Mylonakis | Q56769876 |
| P2093 | author name string | Anastasios Mavrakis | |
| Herman Anthony Carneiro | |||
| P2860 | cites work | Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality | Q24530412 |
| Candida colonization and subsequent infections in critically ill surgical patients | Q24535524 | ||
| Epidemiological trends in nosocomial candidemia in intensive care | Q25255762 | ||
| Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans | Q28265703 | ||
| Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America | Q28268745 | ||
| Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome | Q28276727 | ||
| Peritonitis into the 1990s: changing pathogens and changing strategies in the critically ill | Q30434902 | ||
| The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation | Q30464349 | ||
| Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia | Q33296907 | ||
| Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans | Q33369708 | ||
| Use of mass spectrometry to identify clinical Fusarium isolates | Q33448860 | ||
| High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories | Q33522362 | ||
| Rapid species diagnosis for invasive candidiasis using mass spectrometry | Q33527403 | ||
| Candida peritonitis. Report of 22 cases and review of the English literature | Q33542067 | ||
| Yeasts in the gut: from commensals to infectious agents | Q33579140 | ||
| Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. | Q33704835 | ||
| The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients | Q33887429 | ||
| The microbiology of postoperative peritonitis. | Q53993089 | ||
| Microbiologic features and treatment of persistent peritonitis in patients in the intensive care unit. | Q54778132 | ||
| Tertiary Peritonitis: Clinical Features of a Complex Nosocomial Infection | Q61440618 | ||
| Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis | Q63681583 | ||
| Pharmacokinetics of antifungal agents | Q70481603 | ||
| The role of Candida in intraperitoneal infections | Q71343063 | ||
| Trends in the postmortem epidemiology of invasive fungal infections at a university hospital | Q71618317 | ||
| Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation | Q71998216 | ||
| Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide | Q72283657 | ||
| Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party | Q72895880 | ||
| Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? | Q73101668 | ||
| Invasive Candida enteritis of the newborn | Q73122266 | ||
| Comparison of glucan detection and galactomannan enzyme immunoassay in gastrointestinal and systemic murine candidiasis | Q73648399 | ||
| Detection of Candida species by polymerase chain reaction (PCR) in blood samples of experimentally infected mice and patients with suspected candidemia | Q73926460 | ||
| Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC) | Q78144262 | ||
| Efficacy of antibacterial drugs in mice with complex infection by Candida albicans and Escherichia coli | Q78201045 | ||
| Successful treatment of eight episodes of Candida peritonitis without catheter removal using intracatheter administration of amphotericin B | Q79771393 | ||
| [Procalcitonin in invasive candidosis] | Q79923039 | ||
| Candida as a risk factor for mortality in peritonitis | Q82677695 | ||
| Candida in the peritoneum: passenger or pathogen? | Q82677819 | ||
| Host-microbe interactions in stem cell transplantation: recognizing Candida in infection and inflammation | Q82997437 | ||
| Candida infection and colonization in critically ill surgical patients | Q82997541 | ||
| Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat | Q83391830 | ||
| [The preemptive treatment of invasive Candida infection with reference of corrected colonization index in critically ill patients: a multicenter, prospective, randomized controlled clinical study] | Q84555730 | ||
| Response of mice to the inoculations of both Candida albicans and Escherichia coli. I. The enhancement phenomenon | Q33966795 | ||
| Pseudomonas-Candida interactions: an ecological role for virulence factors | Q34134632 | ||
| Statin therapy and decreased incidence of positive Candida cultures among patients with type 2 diabetes mellitus undergoing gastrointestinal surgery. | Q34374275 | ||
| Procalcitonin as an acute phase marker | Q34391901 | ||
| Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? | Q34490092 | ||
| Candida infection and colonization among non-trauma emergency surgery patients | Q34625968 | ||
| Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections | Q34900399 | ||
| Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. | Q34936576 | ||
| Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients | Q35018807 | ||
| Diagnosis of fungal infection: new technologies for the mycology laboratory | Q35027491 | ||
| Management of invasive candidiasis in critically ill patients | Q35904821 | ||
| Peritoneal dialysis-related infections recommendations: 2005 update. | Q36082727 | ||
| Critical issues in the clinical management of complicated intra-abdominal infections | Q36214662 | ||
| Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis | Q36261766 | ||
| Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality | Q36338910 | ||
| Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials | Q36387455 | ||
| Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis | Q36455512 | ||
| Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations | Q36491819 | ||
| Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies | Q36506378 | ||
| New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage | Q36597431 | ||
| Developments in the treatment of candidiasis: more choices and new challenges | Q36623050 | ||
| Use of DNA microarray technology and gene expression profiles to investigate the pathogenesis, cell biology, antifungal susceptibility and diagnosis of Candida albicans | Q36624102 | ||
| Bench-to-bedside review: Candida infections in the intensive care unit | Q36641985 | ||
| Candida peritonitis | Q36747154 | ||
| Posaconazole: a new broad-spectrum antifungal agent | Q36828159 | ||
| Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigens | Q36900157 | ||
| Posaconazole in the management of refractory invasive fungal infections | Q37052755 | ||
| Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes | Q37054102 | ||
| Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium | Q37190996 | ||
| Quorum sensing and Candida albicans | Q37317066 | ||
| Update on fungal peritonitis and its treatment. | Q37409041 | ||
| An update on the molecular diagnosis of invasive fungal disease | Q37470831 | ||
| Quorum sensing and fungal-bacterial interactions in Candida albicans: a communicative network regulating microbial coexistence and virulence. | Q37618673 | ||
| Candida colonization and candiduria in critically ill patients in the intensive care unit | Q37624708 | ||
| Invasive fungal infections: the challenge continues | Q37624712 | ||
| Medically important bacterial-fungal interactions | Q37720396 | ||
| Evaluating evidence and grading recommendations: the SIS/IDSA guidelines for the treatment of complicated intra-abdominal infections. | Q37768162 | ||
| Antifungal susceptibility testing and candidaemia at a tertiary referral hospital. | Q37861676 | ||
| An in vitro model to assess mucosal immune function and bacterial translocation | Q38504932 | ||
| Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice | Q40166357 | ||
| Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis | Q40390928 | ||
| Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery | Q40490450 | ||
| Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice. | Q40599677 | ||
| Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B. | Q40846628 | ||
| Fungal septicemia in surgical patients | Q40901691 | ||
| Microbial synergy in experimental intra-abdominal abscess | Q40904809 | ||
| Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence | Q41030213 | ||
| Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection | Q41111401 | ||
| International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections | Q41550505 | ||
| Antibiotic therapy for abdominal infection | Q41694826 | ||
| Bacterial peptidoglycan-derived molecules activate Candida albicans hyphal growth | Q41865014 | ||
| In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species | Q42084568 | ||
| Synergistic effects of Candida and Escherichia coli on gut barrier function | Q42481496 | ||
| Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death | Q43142736 | ||
| The value of neopterin and procalcitonin in patients with sepsis | Q43172331 | ||
| The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis | Q43294591 | ||
| Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model | Q43506631 | ||
| Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. | Q43823539 | ||
| Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations | Q43980210 | ||
| Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? | Q44171879 | ||
| Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B. | Q44176564 | ||
| Peritoneal infection with multiple species of Candida: a case report | Q44320356 | ||
| Candida infection and colonization among trauma patients | Q44381353 | ||
| Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis | Q44455401 | ||
| Rapid identification of Candida spp. in peritonitis patients by Raman spectroscopy | Q44844591 | ||
| Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies | Q44913001 | ||
| Case report: spontaneous peritonitis caused by Candida albicans | Q45203071 | ||
| Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). | Q46072663 | ||
| Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients | Q46145337 | ||
| Serologic diagnosis of fungal infections | Q46206854 | ||
| A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals | Q46226099 | ||
| Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p | Q46487837 | ||
| Clinical significance of Candida isolated from peritoneum in surgical patients | Q46626022 | ||
| Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists | Q46711915 | ||
| Significance of intraoperative peritoneal culture of fungus in perforated peptic ulcer | Q47599065 | ||
| Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia | Q47653393 | ||
| Real-time LightCycler polymerase chain reaction and melting temperature analysis for identification of clinically important Candida spp. | Q50576165 | ||
| Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. | Q51193935 | ||
| A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. | Q51948770 | ||
| Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis. | Q53854409 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 2650-2659 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | World Journal of Surgery | Q15763279 |
| P1476 | title | Candida peritonitis: an update on the latest research and treatments | |
| P478 | volume | 35 |
| Q40833322 | A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. |
| Q34597421 | Abdominal candidiasis is a hidden reservoir of echinocandin resistance |
| Q30411367 | Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome |
| Q92002034 | Beyond tissue concentrations: antifungal penetration at the site of infection |
| Q36911444 | Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity |
| Q42735489 | Candida glabrata intra-abdominal candidiasis is characterized by persistence within the peritoneal cavity and abscesses |
| Q64104742 | Concomitant fungal peritonitis and high ascitic amylase as a rare manifestation of gastric perforation |
| Q38149163 | Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients |
| Q45978085 | Invasive Candida Infection after Upper Gastrointestinal Tract Surgery for Gastric Cancer. |
| Q38614492 | Invasive candidiasis: future directions in non-culture based diagnosis |
| Q36410987 | Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus |
| Q92539733 | Perforated and bleeding peptic ulcer: WSES guidelines |
| Q92088355 | Peritoneal irrigation vs suction alone during pediatric appendectomy for perforated appendicitis: A meta-analysis |
| Q37213005 | Profiling of Candida albicans gene expression during intra-abdominal candidiasis identifies biologic processes involved in pathogenesis. |
| Q89122069 | The Clinical Outcome of Postoperative Invasive Fungal Infections Complicating Laparoscopic Sleeve Gastrectomy |
| Q40121744 | Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-Abdominal Abscess Model. |
Search more.